{"entity":{"type":"insider","cik":"0001338185","url":"/insider/0001338185","json_url":"/insider/0001338185.json","name":"Davis Thomas Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2006-01-05","last":"2022-04-05","span_basis":"filed_date"},"name_variants":[{"name":"Davis Thomas Andrew","source":"filing","n_filings":5,"first_seen":"2006-01-05","last_seen":"2022-04-05"}],"transactions":[{"id":6684469,"accession":"0001457612-22-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000044","line_url":"/filing/0001457612-22-000044#line-1","is_derivative":false,"issuer_cik":"0001338185","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001338185","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (CHIEF MEDICAL OFFICER)","officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1091.0,"shares_display":"1,091","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":1363.75,"total_display":"1,363.75","shares_owned_after":68330.0,"shares_owned_after_display":"68,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":6513720,"accession":"0001457612-22-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001457612-22-000028","line_url":"/filing/0001457612-22-000028#line-2","is_derivative":false,"issuer_cik":"0001338185","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001338185","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (CHIEF MEDICAL OFFICER)","officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2717.0,"shares_display":"2,717","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":2988.7,"total_display":"2,988.70","shares_owned_after":69421.0,"shares_owned_after_display":"69,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-17","scope":"insider"},{"id":6483121,"accession":"0001457612-22-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001457612-22-000018","line_url":"/filing/0001457612-22-000018#line-2","is_derivative":false,"issuer_cik":"0001338185","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001338185","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (CHIEF MEDICAL OFFICER)","officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524.0,"shares_display":"524","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":1168.52,"total_display":"1,168.52","shares_owned_after":48700.0,"shares_owned_after_display":"48,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2022-03-16","scope":"insider"},{"id":6483117,"accession":"0001457612-22-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000018","line_url":"/filing/0001457612-22-000018#line-1","is_derivative":false,"issuer_cik":"0001338185","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001338185","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (CHIEF MEDICAL OFFICER)","officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":948.0,"shares_display":"948","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":2569.08,"total_display":"2,569.08","shares_owned_after":49224.0,"shares_owned_after_display":"49,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-02","filed_date":"2022-03-16","scope":"insider"},{"id":7135000,"accession":"0001179110-10-013921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-10-013921","line_url":"/filing/0001179110-10-013921#line-2","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (Sr. VP & CMO)","officer_title":"Sr. VP & CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1489.0,"shares_display":"1,489","price_per_share":3.77,"price_display":"3.77","price_state":"stated","total_value":5613.53,"total_display":"5,613.53","shares_owned_after":1489.0,"shares_owned_after_display":"1,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-16","filed_date":"2010-09-17","scope":"insider"},{"id":7134997,"accession":"0001179110-10-013921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-10-013921","line_url":"/filing/0001179110-10-013921#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"Celldex Therapeutics, Inc.","issuer_ticker":"CLDX","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (Sr. VP & CMO)","officer_title":"Sr. VP & CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1011.0,"shares_display":"1,011","price_per_share":3.78,"price_display":"3.78","price_state":"stated","total_value":3821.58,"total_display":"3,821.58","shares_owned_after":1011.0,"shares_owned_after_display":"1,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-16","filed_date":"2010-09-17","scope":"insider"},{"id":4375958,"accession":"0001140361-06-000271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-06-000271","line_url":"/filing/0001140361-06-000271#line-1","is_derivative":false,"issuer_cik":"0000934473","issuer_name":"GENVEC INC","issuer_ticker":"GNVC","issuer_name_source":null,"issuer_url":"/issuer/0000934473","owner_cik":"0001338185","owner_name":"Davis Thomas Andrew","owner_url":"/insider/0001338185","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":9100.0,"total_display":"9,100.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-22","filed_date":"2006-01-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":3,"first_seen":"2022-03-16","last_seen":"2022-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"Celldex Therapeutics, Inc.","url":"/issuer/0000744218","role":"Officer (Sr. VP & CMO)","n_filings":1,"first_seen":"2010-09-17","last_seen":"2010-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000934473","name":"GENVEC INC","url":"/issuer/0000934473","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2006-01-05","last_seen":"2006-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001338185","retrieved_at":"2026-08-22T04:11:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}